For: | Mwinyi J, Wenger C, Eloranta JJ, Kullak-Ublick GA. Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J Gastroenterol 2010; 16(31): 3888-3896 [PMID: 20712049 DOI: 10.3748/wjg.v16.i31.3888] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i31/3888.htm |
Number | Citing Articles |
1 |
Mesut Savas, Elisabeth F.C. van Rossum. Encyclopedia of Endocrine Diseases. 2019; : 147 doi: 10.1016/B978-0-12-801238-3.65339-4
|
2 |
Qian-Qian Song, Wan-Ying Xie, Yong-Jun Tang, Jun Zhang, Jie Liu. Genetic Variation in the Glucocorticoid Pathway Involved in Interindividual Differences in the Glucocorticoid Treatment. Pharmacogenomics 2017; 18(3): 293 doi: 10.2217/pgs-2016-0151
|
3 |
Sarah Tayler, Katarina Hazuchova, Anna Riddle, James W. Swann, Barbara Glanemann. Investigation of single‐nucleotide polymorphisms in the NR3C1a glucocorticoid receptor gene in Cocker Spaniels with primary immune thrombocytopenia. Journal of Veterinary Internal Medicine 2022; 36(4): 1281 doi: 10.1111/jvim.16468
|
4 |
MICHAŁ PANEK, TADEUSZ PIETRAS, ARTUR FABIJAN, MACIEJ MIŁANOWSKI, ŁUKASZ WIETESKA, PAWEŁ GÓRSKI, PIOTR KUNA, JANUSZ SZEMRAJ. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Experimental and Therapeutic Medicine 2013; 5(2): 572 doi: 10.3892/etm.2012.809
|
5 |
Seyede Mina Hejazian, Sepideh Zununi Vahed, Hakimeh Moghaddas Sani, Ziba Nariman-Saleh-Fam, Milad Bastami, Seyed Mahdi Hosseiniyan Khatibi, Mohammadreza Ardalan, Nasser Samadi. Steroid-resistant nephrotic syndrome: pharmacogenetics and epigenetic points and views. Expert Review of Clinical Pharmacology 2020; 13(2): 147 doi: 10.1080/17512433.2020.1702877
|
6 |
A. Costa, R. K. Sellon, M. Court, N. S. Burke, K. L. Mealey. Polymorphisms in the canine glucocorticoid receptor alpha gene (NR3C1α). Journal of Veterinary Pharmacology and Therapeutics 2016; 39(1): 16 doi: 10.1111/jvp.12241
|
7 |
Sara Rufini, Cinzia Ciccacci, Giuseppe Novelli, Paola Borgiani. Pharmacogenetics of Inflammatory Bowel Disease: A Focus on Crohn’S Disease. Pharmacogenomics 2017; 18(11): 1095 doi: 10.2217/pgs-2017-0068
|
8 |
Shannon D Whirledge, Christine M Jewell, Lisa M Barber, Xiaojiang Xu, Kevin S Katen, Stavros Garantziotis, John A Cidlowski. Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptor. Laboratory Investigation 2017; 97(11): 1282 doi: 10.1038/labinvest.2017.76
|
9 |
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12): 1209 doi: 10.1080/17425255.2018.1551876
|
10 |
Jan W. Koper, Elisabeth F.C. van Rossum, Erica L.T. van den Akker. Glucocorticoid receptor polymorphisms and haplotypes and their expression in health and disease. Steroids 2014; 92: 62 doi: 10.1016/j.steroids.2014.07.015
|
11 |
Marcin Gabryel, Marzena Skrzypczak-Zielinska, Marcin A. Kucharski, Ryszard Slomski, Agnieszka Dobrowolska. The impact of genetic factors on response to glucocorticoids therapy in IBD. Scandinavian Journal of Gastroenterology 2016; 51(6): 654 doi: 10.3109/00365521.2015.1132336
|
12 |
Marianne Sidoroff, Kaija-Leena Kolho. Glucocorticoid sensitivity in inflammatory bowel disease. Annals of Medicine 2012; 44(6): 578 doi: 10.3109/07853890.2011.590521
|
13 |
Hong-Lin Chen, Li-Ren Li. Glucocorticoid Receptor Gene Polymorphisms and Glucocorticoid Resistance in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences 2012; 57(12): 3065 doi: 10.1007/s10620-012-2293-2
|
14 |
Chentao Zou, Xinquan Zan, Zhenyu Jia, Lu Zheng, Yijie Gu, Fei Liu, Ye Han, Chunfang Xu, Airong Wu, Qiaoming Zhi. Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives. Clinical and Translational Medicine 2023; 13(11) doi: 10.1002/ctm2.1479
|
15 |
Sophie E. Berends, Anne S. Strik, Mark Löwenberg, Geert R. D’Haens, Ron A. A. Mathôt. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clinical Pharmacokinetics 2019; 58(1): 15 doi: 10.1007/s40262-018-0676-z
|
16 |
Aleksandra Szczepankiewicz, Anna Leszczyńska-Rodziewicz, Joanna Pawlak, Aleksandra Rajewska-Rager, Monika Dmitrzak-Weglarz, Monika Wilkosc, Maria Skibinska, Joanna Hauser. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. Journal of Affective Disorders 2011; 134(1-3): 138 doi: 10.1016/j.jad.2011.06.020
|
17 |
Perpétua do Socorro Silva Costa, Thayne Woycinck Kowalski, Lucas Rosa Fraga, Mariléa Furtado Feira, Ana Paula Nazário, Luis MarceloAranha Camargo, Daniele Iop de Oliveira Caldoncelli, Maria Irismar da Silva Silveira, Mara Helena Hutz, Lavínia Schüler-Faccini, Fernanda Sales Luiz Vianna.
NR3C1
,
ABCB1
,
TNF
and
CYP2C19
Polymorphisms Association with the Response to the Treatment of Erythema Nodosum Leprosum
. Pharmacogenomics 2019; 20(7): 503 doi: 10.2217/pgs-2018-0192
|
18 |
Cristina Botelho Barra, Thais Ramos Villela, Nedstâni de Freitas Soares, Enrico Antônio Colosimo, André Rolim Belisário, Ana Cristina Simões e Silva, Ivani Novato Silva, Jun Mori. Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia. PLOS ONE 2022; 17(12): e0279298 doi: 10.1371/journal.pone.0279298
|